ABSTRACT. Prenatal exposure to the dopaminc (DA) agonist cocaine, even if limited to early gestation, is associated with impaired developmental outcome in the human infant. \Ye investigated the possible role of neurotrophic factors in this process by evaluating 4-to 6-d-old New Zealand \\'bite rabbit pups ( n = 14) born to cocaineexposed does (30 mg/kg/d s.c. from days 7 to 15 of a 32-d gestation) and control does (sterile H20). Cocaine esposure reduced striatal dopamine by 46% (t = 2.31; p < 0.05) and striatal 3,4-dihydrosyphenyl acetic acid by 49% (t = 2.44; p < 0.05). The number of neuron-specific enolase immunoreactive neurons in mesencephalic cultures incubated with striatal estracts from pups esposed to cocaine was reduced by 61% relative to the effect of striatal estracts from control pups (t = 4.84; p < 0.01). The present results suggest that the reduction in striatal dopamine observed may result from a cocaine-induced decrease in striatal trophic activity. (Pediatr Res 34: 389-392, 1993) Abbreviations DA, doparnine DOPAC, 3,4-dihydrosyphenyl acetic acid E, embryonic P, postnatal IIBSS, Ilanks' balanced salt solution TBS, Tris-buffered saline NSE, neuron-specific enolase NSEir, NSE immu~:oreactive Prenatal exposure to the DA agollist cocaine is associated with impaired developmental outcome in the human infant (1-9). Reported observations include a broad spectrum of abnormalities. However, variability in study methodology, patient populations, and dose, duration, and gestational timing of cocaine exposure prevent a clear understanding of the specific relationship of cocaine to the type and severity of impairment. Mechanisms that may be responsible for the altered developmental outcorne after prenatal cocaine exposure remain elusive. Although speculated, the role of neurotransmitters has not been thorcughly investigated in the human infant. However, recent studies of the DA system of maturing rodents after in lrtcro